Table 1 Characteristics of study participants who did or did not have HIV-related ocular disease (n = 149, unless otherwise specified)
Characteristic | Participants with HIV-related ocular conditions (%) (n = 26) | Participants without HIV related eye conditions (%) (n = 123) | P-value |
|---|---|---|---|
Median age (n = 148) | |||
Years | 38 | 36 | 0.95 |
Gender | |||
Male [n(%)] | 18 (69.2) | 86 (69.9) | 0.94 |
Marital status | |||
Single | 3 (11.5) | 13 (10.6) | 0.81 |
Married | 20 (76.9) | 88 (70.7) | |
Divorced | 0 | 2 (1.6) | |
Widowed | 3 (11.6) | 21 (17.1) | |
Occupation | |||
None | 13 (50.0) | 55 (44.7) | 0.44 |
Unskilled | 2 (7.7) | 22 (17.9) | |
Skilled | 11(42.3) | 46 (37.4) | |
Exposure (n = 147) | |||
Heterosexual | 26 (100.0) | 113 (93.4) | 0.99 |
Homosexual | 0 | 4 (3.3) | |
Blood transfusion | 0 | 2 (1.7) | |
Intravenous drug use | 0 | 2 (1.7) | |
Median CD4 count | |||
Cells/μL | 106 | 200 | 0.003 |
CD4 count (cells/μL) | |||
0-50 | 7 (26.9) | 6 (4.9) | 0.003 |
51-100 | 6 (23.1) | 17 (13.8) | |
101-150 | 5 (19.2) | 18 (14.6) | |
151-200 | 2 (7.7) | 23 (18.7) | |
201-250 | 2 (7.7) | 25 (20.3) | |
>250 | 4 (15.4) | 34 (27.6) | |
WHO clinical stage | |||
1/2 | 2 (7.8) | 58(47.2) | <0.001 |
3/4 | 24 (92.3) | 65 (52.8) | |
Months since HIV diagnosis | |||
≤ 12 | 11 (42.3) | 51 (42.5) | 0.94 |
13-24 | 6 (23.1) | 27 (22.5) | |
25-60 | 5 (19.2) | 28 (23.3) | |
>61 | 4 (15.4) | 14 (11.7) | |
Tuberculosis status | |||
No history | 7 (26.9) | 63 (51.2) | 0.07 |
Past history | 11 (42.3) | 31 (25.2) | |
Current | 8 (30.8) | 29 (23.6) | |
History of eye symptoms (n = 148) | |||
None | 24 (92.3) | 113 (92.6) | 0.82 |
Reduced vision | 2 (7.7) | 6 (4.9) | |
Pain | 0 | 2 (1.6) | |
Floaters | 0 | 1 (0.8) | |
Visual acuity (n = 142) | |||
None | 20 (80.0) | 110 (94.0) | 0.02 |
Visual impairment | 4 (16.0) | 7 (5.6) | |
Blind | 1 (4.0) | 0 |